Study of 3,011 FDA warning letters finds seven citing AI, including earliest CDER letter
A peer-reviewed analysis of 3,011 FDA warning letters found seven references to AI in the areas of medical devices, tobacco products and drug manufacturing. It also identified the earliest CDER warning letter that cites the use of AI.
Who is affected and how
- pharmaceuticals
- The use of AI in manufacturing must be documented and validated within the quality assurance system, as the regulator already refers to it.
- medtech company
- Compliance preparation should include validating AI tools.
Sources
- Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use - EIN Presswireeinnews.com · Nov 4, 2026
- Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Usethe tennessean · Nov 5, 2026
- Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use - The Tennesseantennessean.com · Nov 5, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.